PolyProx Therapeutics ^Company

Protein homeostasis, targetting protein misfolding. PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin molecules, to treat cancer and neurodegenerative diseases. Polyproxin molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.